Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Anti-HER2 immunoliposomes produced enhanced antitumor efficacy via targeted delivery.
Publications
2 shownRationale for Biomarkers and Surrogate End Points in Mechanism-Driven Oncology Drug Development
Recent progress in understanding the molecular basis of cancer has redefined the landscape for cancer drug discovery and development. Among the most exciting and promising benef...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 804
- Institution
- University of California, San Francisco
External Links
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.